4//SEC Filing
Sandborn William J. 4
Accession 0001209191-23-038188
CIK 0001851194other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 9:16 PM ET
Size
8.0 KB
Accession
0001209191-23-038188
Insider Transaction Report
Form 4
Sandborn William J.
See Remarks
Transactions
- Sale
Common Stock
2023-06-15$33.88/sh−2,383$80,730→ 32,279 total(indirect: By Spouse) - Sale
Common Stock
2023-06-15$34.75/sh−1,104$38,362→ 31,175 total(indirect: By Spouse)
Holdings
- 48,389
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on December 19, 2022.
- [F2]Represents the weighted average share price of an aggregate total of 2,383 shares sold in the price range of $33.39 to $34.322. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average share price of an aggregate total of 1,104 shares sold in the price range of $34.445 to $34.9565. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Ventyx Biosciences, Inc.
CIK 0001851194
Entity typeother
Related Parties
1- filerCIK 0001923805
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 9:16 PM ET
- Size
- 8.0 KB